학술논문
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study
Document Type
Article
Author
Bamias, Aristotelis ; Davis, Ian D; Galsky, Matthew D; Arranz, José Á; Kikuchi, Eiji; Grande, Enrique; del Muro, Xavier Garcia; Park, Se Hoon; De Giorgi, Ugo; Alekseev, Boris; Mencinger, Marina; Izumi, Kouji; Schutz, Fabio A; Puente, Javier; Li, Jian-Ri; Panni, Stefano; Gumus, Mahmut; Özgüroğlu, Mustafa; Mariathasan, Sanjeev; Poloz, Yekaterina; Bene-Tchaleu, Fabiola; Lee, Chooi; Bernhard, Sandrine; De Santis, Maria
Source
In The Lancet Oncology January 2024 25(1):46-61
Subject
Language
ISSN
1470-2045